Quantum Genomics Socit Stock Today
| QNNTF Stock | USD 0.10 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Quantum Genomics is trading at 0.1 as of the 4th of May 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.1. Quantum Genomics has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Quantum Genomics Socit are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of April 2024 and ending today, the 4th of May 2024. Click here to learn more.
Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. The company was founded in 2005 and is based in Paris, France. Quantum Genomics is traded on OTC Exchange in the United States. The company has 34.53 M outstanding shares. More on Quantum Genomics Socit
Moving against Quantum Pink Sheet
| 0.62 | GOOG | Alphabet Class C | PairCorr |
| 0.59 | SGEN | Seagen Inc | PairCorr |
| 0.47 | MRNA | Moderna Earnings Call This Week | PairCorr |
| 0.41 | HNHPF | Hon Hai Precision | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Quantum Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Quantum Genomics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Quantum Genomics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Quantum Genomics Socit [QNNTF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 117.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quantum Genomics's market, we take the total number of its shares issued and multiply it by Quantum Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Quantum Genomics Socit classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 34.53 M outstanding shares.
Quantum Genomics Socit has accumulated about 24.87 M in cash with (17.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Quantum Genomics Probability Of Bankruptcy
Ownership AllocationQuantum Genomics owns a total of 34.53 Million outstanding shares. Quantum Genomics holds 9.18 pct. of its outstanding shares held by insiders and 3.69 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Quantum Ownership Details
Quantum Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Quantum Genomics jumping above the current price in 90 days from now is close to 99%. The Quantum Genomics Socit probability density function shows the probability of Quantum Genomics pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Quantum Genomics Socit has a beta of -3.7071 indicating as returns on its benchmark rise, returns on holding Quantum Genomics Socit are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Quantum Genomics is expected to outperform its benchmark. Additionally, quantum Genomics Socit has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Quantum Genomics to move above the current price in 90 days from now is close to 99 (This Quantum Genomics Socit probability density function shows the probability of Quantum Pink Sheet to fall within a particular range of prices over 90 days) .
Quantum Genomics Socit Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Quantum Genomics market risk premium is the additional return an investor will receive from holding Quantum Genomics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Quantum Genomics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Quantum Genomics' alpha and beta are two of the key measurements used to evaluate Quantum Genomics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.9 | |||
| Standard Deviation | 11.95 | |||
| Variance | 142.73 | |||
| Risk Adjusted Performance | (0.07) |
Quantum Stock Against Markets
Picking the right benchmark for Quantum Genomics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Quantum Genomics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Quantum Genomics is critical whether you are bullish or bearish towards Quantum Genomics Socit at a given time. Please also check how Quantum Genomics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Quantum Genomics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Quantum Genomics Corporate Management
Elected by the shareholders, the Quantum Genomics' board of directors comprises two types of representatives: Quantum Genomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quantum. The board's role is to monitor Quantum Genomics' management team and ensure that shareholders' interests are well served. Quantum Genomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quantum Genomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephane Cohen | Chief Officer | Profile | |
| Sarah MerlenBoulenger | Head Affairs | Profile | |
| Bruno Besse | Chief Officer | Profile | |
| Benot Gueugnon | VP Director | Profile | |
| JeanPhilippe Milon | MD CEO | Profile |
How to buy Quantum Pink Sheet?
Before investing in Quantum Genomics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Quantum Genomics. To buy Quantum Genomics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Quantum Genomics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Quantum Genomics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Quantum Genomics Socit stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Quantum Genomics Socit stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Quantum Genomics Socit, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Quantum Genomics Socit?
The danger of trading Quantum Genomics Socit is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Quantum Genomics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Quantum Genomics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Quantum Genomics Socit is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum Genomics Socit. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Quantum Pink Sheet analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |